Wednesday, November 14, 2007

Skyline Ventures Closes $350M Fund

Palo Alto-based healthcare and life sciences investor Skyline Ventures said Wednesday that it has closed a $350M venture capital fund, Skyline V. The firm said that fundraising began in June, and close in late October. Skyline also said it has invested in Dicerna Pharmaceuticals, but did not disclose any information about the company. The new fund should bring Skyline's total under management to around $700M, including Skyline IV, which closed in March of 2005 with $200M in capital. The firm said the new fund will target 15 investments of approximately $15-35M in each portfolio company.